EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Recent advances in the design and development of small molecules against Lpx enzymes for mitigating Pseudomonas aeruginosa infections

Supriyo Saha iD, Nikita Thapliyal iD, Muskan Singh iD, Shahnawaz Ali Bhat iD

Future Medicinal Chemistry · 03.06.2026 · 18 (11) · 1421-1441

DOI: 10.1080/17568919.2026.2658834 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Future Medicinal Chemistry, online erschienen am 16.04.2026. Verfasst von Supriyo Saha und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Drug Design, Small Molecule Libraries, Enzyme Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of infections caused by the gram-negative bacterium Pseudomonas aeruginosa is widely recognized as a major cause of nosocomial infections and antimicrobial resistance. In gram-negative bacteria such as P. aeruginosa, Lipid A helps maintain cell membrane integrity, and targeting its biosynthesis, known as the Raetz pathway, can be a strategic approach to control these infections. The set of Lpx enzymes involved in the synthesis of Lipid A serves as a potential target for inhibiton. This review outlines strategies for the design and development of small-molecule inhibitors of enzymes that inhibit bacterial growth and mitigate infection. In silico techniques and synthetic procedures have been employed to develop inhibitors targeting a specific enzyme. The presence of the UDP-GlcNAc group, acyl chain-binding group, five-membered ring, amide group, benzamide group, heteroatom, and fused rings is a key set of features that provides a basic scaffold for designing Lpx inhibitors. The structural characteristics of the receptor responsible for prominent ligand interactions have also been discussed, providing a foundation for the development of selective and potent inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas aeruginosaDrug DesignSmall Molecule LibrariesEnzyme InhibitorsAnti-Bacterial AgentsPseudomonas InfectionsAmidohydrolasesHumans

Stichwörter der Autor:innen

Lpx enzymesLpx inhibitorsPseudomonas aeruginosaRaetz pathwaystructural features

Substanzen

Small Molecule LibrariesEnzyme InhibitorsAnti-Bacterial AgentsAmidohydrolases

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India.
  • Department of Zoology, Aligarh Muslim University, Aligarh, India.

ORCID-Profile: Supriyo Saha, Nikita Thapliyal, Muskan Singh, Shahnawaz Ali Bhat

Zitieren

APA

Saha, S., Thapliyal, N., Singh, M., & Ali Bhat, S. (2026). Recent advances in the design and development of small molecules against Lpx enzymes for mitigating Pseudomonas aeruginosa infections. Future Medicinal Chemistry, 18(11), 1421-1441. https://doi.org/10.1080/17568919.2026.2658834

Vancouver

Saha S, Thapliyal N, Singh M, Ali Bhat S. Recent advances in the design and development of small molecules against Lpx enzymes for mitigating Pseudomonas aeruginosa infections. Future Medicinal Chemistry. 2026;18(11):1421-1441. doi:10.1080/17568919.2026.2658834

BibTeX
@article{Saha2026,
  author = {Saha, Supriyo and Thapliyal, Nikita and Singh, Muskan and Ali Bhat, Shahnawaz},
  title = {Recent advances in the design and development of small molecules against Lpx enzymes for mitigating Pseudomonas aeruginosa infections},
  journal = {Future Medicinal Chemistry},
  year = {2026},
  volume = {18},
  number = {11},
  pages = {1421--1441},
  doi = {10.1080/17568919.2026.2658834}
}
Kostenlos starten →